Dec 05, 09:08
Dec 05, 09:07
|NSE SERIES||LAST PRICE||CHANGE(%)||OPEN||HIGH||LOW||FACE VALUE|
|Company Name||Last Price||%
|Dr Reddys Labs||2413.15||-1.52||2545.00||1764.00||41,047.62|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|Scheme||No. of Shares|
|Franklin India Bluechip Fund (G)||824,546|
|DSP BlackRock Top 100 Equity Fund - Regular Plan (G)||610,510|
|ICICI Prudential Focused Bluechip Equity Fund (G)||520,359|
|HDFC Top 200 Fund (G)||487,749|
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 41,047.62 crore.The company has reported a consolidated sales of Rs 3357.45 crore and a Net Profit of Rs 690.25 crore for the quarter ended Sep 2013.
The company management includes G V Prasad - Chairman & CEO, Satish Reddy - Vice Chairman & Mng.Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Kalpana Morparia - Independent Director, Omkar Goswami - Independent Director, Ravi Bhoothalingam - Independent Director, Sridar Iyengar - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.